Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Beam Therapeutics Inc. (BEAM) had Weighted-Average Shares Outstanding (Diluted) of 87.98M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$7.47M |
|
$-109.27M |
|
-- |
|
$7.47M |
|
$126.76M |
|
$-119.29M |
|
$10.02M |
|
$-109.27M |
|
$-109.27M |
|
$-109.27M |
|
$-109.27M |
|
$-109.27M |
|
$-109.27M |
|
$-119.29M |
|
$-117.61M |
|
87.98M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
87.98M |
$-1.24 |
|
$-1.24 |
|
| Balance Sheet Financials | |
$1.25B |
|
$109.57M |
|
$219.31M |
|
$1.47B |
|
$141.55M |
|
-- |
|
$202.24M |
|
$343.78M |
|
$1.12B |
|
$1.12B |
|
$1.12B |
|
100.56M |
|
| Cash Flow Statement Financials | |
$-103.88M |
|
$-125.09M |
|
$473.38M |
|
$290.11M |
|
$534.52M |
|
$244.41M |
|
$26.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1596.87% |
|
-1596.87% |
|
-- |
|
-1462.78% |
|
-1462.78% |
|
$-106.95M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-9.73% |
|
-9.73% |
|
-7.45% |
|
-9.73% |
|
$11.17 |
|
$-1.22 |
|
$-1.18 |
|